Aggressive brain tumours carry potential target for engineered immune cells


Anne Li                                                                                     March 11th, 2018


A molecule on glioblastoma cells that could be used as a target for genetically engineered immune cells has been identified. Researchers at the University of North Carolina found a molecule called CSPG4 in two thirds of tumour samples from 46 patients with glioblastoma. Dr Martin Pule, a Cancer Research UK-funded immunotherapy expert, said finding CSPG4 on the majority of glioblastoma cells suggests it could be tested as a possible treatment target for a broad range of patients.
See original article at:


  1. StevAvaimb says

    Can Canine Be Given People Amoxicillin Kamagra Jelly Potenz Cialis Acheter Nolvadex Proviron Acheter Cialis 20mg Generic Levitra Overnight

  2. curso face ads says

    Quando tiver criado um programa adequado às suas necessidades, terá de construir uma base de clientes, e continuar a encontrar novos clientes para trazer.

Post a comment